The global bioreactors market is expected to reach to USD 1,417 Million by 2021 from USD 955 Million in 2015, at a CAGR of 6.8% between 2015 and 2021.
The increase in adoption of single-use technologies,
use of hybrid technologies: single-use and stainless steel, growing
popularity of single-use bioreactor among biopharmaceutical companies,
and growing biologics are spurring the growth of the bioreactors market.
However, regulatory concerns related to single-use bioreactors, issues
regarding leachable and extractable related to single-use bags is
hampering the growth of this market.
By material, single-use bioreactors are expected to
register second highest growth by volume during the forecast period from
2016 to 2021. High growth in this segment is attributed to the
advantages of SUBs such as reduced need for cleaning and sterilization,
reduced risk of cross contamination, and greater control over aseptic
conditions.
Bioreactors are mainly used for growing organisms
such as bacteria or yeast that are used in the biotechnological
production of substances such as pharmaceuticals, antibodies, and
vaccines or for bioconversion of organic waste. By usage, it is
segmented into lab-scale, pilot-scale and full-scale production. The
lab-scale production segment will witness maximum growth by volume from
2016 to 2021, owing to process development in R&D departments.
By control type, the bioreactor market is segmented
into manual and automated control type. In 2015, in terms of volume, the
automated control type segment accounted for the largest share of the
bioreactors market. In the present scenario, the preference for mass
flow controllers (MFCs) is growing, resulting into usage of automated
control type. This is because they add additional security assurance and
reduce the operating costs of bioreactors. Running bioreactors on MFCs
does not require skilled labour. As a result, an increasing number of
companies are opting for MFCs.
The bioreactors market is a competitive market with a
large number of companies operational in the market. The competitive
landscape includes an in-depth market share analysis along with the key
business strengths of leading players in the market. Some of the leading
players offering bioreactor products are Sartorius AG (Germany), Thermo
Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (A
subsidiary of General Electric Company) (U.S.), Danaher Corporation
(U.S), Eppendorf AG (Germany).
Comments
Post a Comment